Priority Date: 16.08.10 (US 20100374106P)

CAMKK-BETA AS A TARGET FOR TREATING CANCER

  • Application ID: EP11818636
  • Status: EXAMINATION IN PROGRESS

Applicant

Research organisation logo small
Research Organisation

Attorney

Employment test 201 - 500 employees
Company dna grunecker kinkeldey stockmair and schwanhausser
operating since 1924
Headquarter in Munich and 2 offices
active in Legal Services

Specialization

This EP application has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING). We found, that TransMIT GmbH, Kailuweit & Uhlemann, Sperling Fischer & Heyner, Zacco, Lederer Keller Patentanwälte Partnerschaft mbB and 184 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 16.08.2010 - Priority Date (US 20100374106P)
  • 23.02.2012 - Publication A2 (WO2012024255)
  • 26.06.2013 - Publication A2 (EP2606130)

IPC Classification